Hydroxypinacolone Retinoate (HPR): Evidence and US Claim Limits
What hydroxypinacolone retinoate (HPR) is, what its human studies actually tested, and which US and Korean claims an HPR serum can make.
Non-Comedogenic Testing for Korean Skincare: MFDS and US Claim Rules
How to back a non-comedogenic claim on Korea-made skincare: which test to book, what MFDS asks for, how US claim law reads it, and the acne drug line.
Kids and Tween Skincare From Korea: Safe-Formula Rules Compared
Korea regulates cosmetics for kids up to age 13 with a safety file. The EU and US use different rules. Compare all three before you brief a factory.
HRIPT vs Clinical vs Consumer Testing: Substantiating K-Beauty Claims
Which test backs “dermatologist tested,” “hypoallergenic,” or “clinically proven”? HRIPT, clinical, and consumer studies compared for K-beauty founders.
Squalane in Korean K-Beauty: An Indie Founder's 2027 Sourcing and Formulation Guide
Squalane sourcing from Korean ODMs: sugarcane vs olive, MFDS and MoCRA compliance, formulation grade, and the one-page ODM brief indie K-beauty founders need.
Korean ODM vs Chinese ODM: An Indie K-Beauty Founder's Decision Guide (2026)
Korea vs China for K-beauty manufacturing: six structural factors indie founders weigh in 2026 (regulatory path, trend cycle, buyer perception, cost).
How to Audit a Korean ODM: 10-Step Founder's Diligence Playbook
A 10-step audit playbook for indie K-beauty founders before signing with a Korean ODM: MFDS, FDA MOCRA, ISO 22716, formula IP, MOQ, reorder terms.
Is Your K-Beauty Formula Legal in Korea? An Indie Founder's 2026 MFDS Ingredient Guide
Korea regulates cosmetic ingredients through four MFDS lists. A formula legal in the US is not automatic. Here is the 2026 indie founder reference.